Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baudouin Standaert

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
BMC Medicine|July 12, 2011
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the worldMaarten J Postma, Mark Jit, Mark H Rozenbaum, et al.
Vaccine|August 26, 2015
Cost effectiveness evaluation of a rotavirus vaccination program in ArgentinaSebastián García Martí, Andrea Alcaraz, Pilar Valanzasca, et al.
Human Vaccines & Immunotherapeutics|December 12, 2022
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countriesAlen Marijam, Lode Schuerman, Patricia Izurieta, et al.
Applied Health Economics and Health Policy|November 23, 2019
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration ProjectBaudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, et al.
Vaccine|July 28, 2020
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership projectDebbie Van Baarle, Kaatje Bollaerts, Giuseppe Del Giudice, et al.
Vaccine|November 26, 2008
Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenariosEugenio Suárez, Jennifer S Smith, F Xavier Bosch, et al.
Vaccine|November 26, 2008
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccinationDonna Debicki, Nicole Ferko, Nadia Demarteau, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force ReportJosephine Mauskopf, Baudouin Standaert, Mark P Connolly, et al.
BMJ Open|May 18, 2019
Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UKEllen Heinsbroek, Daniel Hungerford, Richard P D Cooke, et al.
Vaccines|February 28, 2023
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare BudgetRitika Kapoor, Baudouin Standaert, Edmund J Pezalla, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
BMC Medicine|July 12, 2011
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the worldMaarten J Postma, Mark Jit, Mark H Rozenbaum, et al.
Vaccine|August 26, 2015
Cost effectiveness evaluation of a rotavirus vaccination program in ArgentinaSebastián García Martí, Andrea Alcaraz, Pilar Valanzasca, et al.
Human Vaccines & Immunotherapeutics|December 12, 2022
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countriesAlen Marijam, Lode Schuerman, Patricia Izurieta, et al.
Applied Health Economics and Health Policy|November 23, 2019
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration ProjectBaudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, et al.
Vaccine|July 28, 2020
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership projectDebbie Van Baarle, Kaatje Bollaerts, Giuseppe Del Giudice, et al.
Vaccine|November 26, 2008
Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenariosEugenio Suárez, Jennifer S Smith, F Xavier Bosch, et al.
Vaccine|November 26, 2008
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccinationDonna Debicki, Nicole Ferko, Nadia Demarteau, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force ReportJosephine Mauskopf, Baudouin Standaert, Mark P Connolly, et al.
BMJ Open|May 18, 2019
Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UKEllen Heinsbroek, Daniel Hungerford, Richard P D Cooke, et al.
Vaccines|February 28, 2023
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare BudgetRitika Kapoor, Baudouin Standaert, Edmund J Pezalla, et al.
Pageof 6